Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Building collapse in Brooklyn kills at least 2, injures more than 10
Israeli strike on southern Gaza hospital kills six
Saudi Arabia says debris from intercepted Houthi missiles falls in Mecca region
Climate crisis is 'outrunning us', UN chief warns COP31
